Sialix announces blood test results of antibodies to diagnose breast cancer

[News]

Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.

More... (http://www.news-medical.net/news/20110420/Sialix-announces-blood-test-results-of-antibodies-to-diagnose-breast-cancer.aspx)